Gudmundsdottir, Hallbera
Cleary, Sean P.
Halfdanarson, Thorvardur R.
Article History
Received: 19 June 2023
Accepted: 19 June 2023
First Online: 2 July 2023
Disclosures
: Dr. Thor Halfdanarson reports research support from Thermo Fisher Scientific, Advanced Accelerator Applications (a Novartis company), Camurus, Crinetics, and Isotopen Technologien Muenchen (ITM) and consulting or being on the advisory board of Ipsen, TerSera, Advanced Accelerator Applications (a Novartis company), Isotopen Technologien Muenchen (ITM), Crinetics, Viewpoint Molecular Targeting, and Camurus.